Annual CFO
-$8.27 M
+$653.20 K+7.32%
April 30, 2024
Summary
- As of February 8, 2025, ALZN annual cash flow from operations is -$8.27 million, with the most recent change of +$653.20 thousand (+7.32%) on April 30, 2024.
- During the last 3 years, ALZN annual CFO has fallen by -$5.56 million (-204.94%).
- ALZN annual CFO is now -691.24% below its all-time high of -$1.05 million, reached on April 30, 2019.
Performance
ALZN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$3.40 M
-$2.34 M-222.07%
October 31, 2024
Summary
- As of February 8, 2025, ALZN quarterly cash flow from operations is -$3.40 million, with the most recent change of -$2.34 million (-222.07%) on October 31, 2024.
- Over the past year, ALZN quarterly CFO has dropped by -$2.34 million (-222.07%).
- ALZN quarterly CFO is now -1557.78% below its all-time high of -$205.10 thousand, reached on July 31, 2020.
Performance
ALZN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$7.91 M
-$1.89 M-31.30%
October 31, 2024
Summary
- As of February 8, 2025, ALZN TTM cash flow from operations is -$7.91 million, with the most recent change of -$1.89 million (-31.30%) on October 31, 2024.
- Over the past year, ALZN TTM CFO has dropped by -$1.89 million (-31.30%).
- ALZN TTM CFO is now -3758.70% below its all-time high of -$205.10 thousand, reached on July 31, 2020.
Performance
ALZN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ALZN Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +7.3% | -222.1% | -31.3% |
3 y3 years | -204.9% | -222.1% | -31.3% |
5 y5 years | -691.2% | -222.1% | -31.3% |
ALZN Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -204.9% | +7.3% | -222.1% | at low | -31.3% | +18.3% |
5 y | 5-year | -691.2% | +7.3% | -1557.8% | at low | -3758.7% | +18.3% |
alltime | all time | -691.2% | +7.3% | -1557.8% | at low | -3758.7% | +18.3% |
Alzamend Neuro Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Oct 2024 | - | -$3.40 M(+222.1%) | -$7.91 M(+31.3%) |
Jul 2024 | - | -$1.06 M(-26.0%) | -$6.03 M(-27.1%) |
Apr 2024 | -$8.27 M(-7.3%) | -$1.43 M(-29.8%) | -$8.27 M(-8.9%) |
Jan 2024 | - | -$2.03 M(+34.2%) | -$9.08 M(+2.5%) |
Oct 2023 | - | -$1.51 M(-54.1%) | -$8.85 M(-8.6%) |
Jul 2023 | - | -$3.30 M(+47.6%) | -$9.68 M(+8.5%) |
Apr 2023 | -$8.92 M(+34.9%) | -$2.24 M(+23.7%) | -$8.92 M(+8.2%) |
Jan 2023 | - | -$1.81 M(-22.9%) | -$8.25 M(+0.3%) |
Oct 2022 | - | -$2.34 M(-7.6%) | -$8.23 M(+3.8%) |
Jul 2022 | - | -$2.54 M(+62.4%) | -$7.93 M(+19.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Apr 2022 | -$6.61 M(+143.9%) | -$1.56 M(-12.4%) | -$6.61 M(+4.8%) |
Jan 2022 | - | -$1.78 M(-12.9%) | -$6.31 M(+18.3%) |
Oct 2021 | - | -$2.05 M(+67.4%) | -$5.33 M(+43.0%) |
Jul 2021 | - | -$1.22 M(-2.8%) | -$3.73 M(+37.5%) |
Apr 2021 | -$2.71 M(+15.6%) | -$1.26 M(+56.0%) | -$2.71 M(+86.5%) |
Jan 2021 | - | -$806.10 K(+82.0%) | -$1.45 M(+124.4%) |
Oct 2020 | - | -$442.90 K(+115.9%) | -$648.00 K(+215.9%) |
Jul 2020 | - | -$205.10 K | -$205.10 K |
Apr 2020 | -$2.35 M(+124.4%) | - | - |
Apr 2019 | -$1.05 M | - | - |
FAQ
- What is Alzamend Neuro annual cash flow from operations?
- What is the all time high annual CFO for Alzamend Neuro?
- What is Alzamend Neuro annual CFO year-on-year change?
- What is Alzamend Neuro quarterly cash flow from operations?
- What is the all time high quarterly CFO for Alzamend Neuro?
- What is Alzamend Neuro quarterly CFO year-on-year change?
- What is Alzamend Neuro TTM cash flow from operations?
- What is the all time high TTM CFO for Alzamend Neuro?
- What is Alzamend Neuro TTM CFO year-on-year change?
What is Alzamend Neuro annual cash flow from operations?
The current annual CFO of ALZN is -$8.27 M
What is the all time high annual CFO for Alzamend Neuro?
Alzamend Neuro all-time high annual cash flow from operations is -$1.05 M
What is Alzamend Neuro annual CFO year-on-year change?
Over the past year, ALZN annual cash flow from operations has changed by +$653.20 K (+7.32%)
What is Alzamend Neuro quarterly cash flow from operations?
The current quarterly CFO of ALZN is -$3.40 M
What is the all time high quarterly CFO for Alzamend Neuro?
Alzamend Neuro all-time high quarterly cash flow from operations is -$205.10 K
What is Alzamend Neuro quarterly CFO year-on-year change?
Over the past year, ALZN quarterly cash flow from operations has changed by -$2.34 M (-222.07%)
What is Alzamend Neuro TTM cash flow from operations?
The current TTM CFO of ALZN is -$7.91 M
What is the all time high TTM CFO for Alzamend Neuro?
Alzamend Neuro all-time high TTM cash flow from operations is -$205.10 K
What is Alzamend Neuro TTM CFO year-on-year change?
Over the past year, ALZN TTM cash flow from operations has changed by -$1.89 M (-31.30%)